nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ANA as an entry criterion for the classification of SLE
|
Pisetsky, David S. |
|
|
18 |
12 |
p. |
artikel |
2 |
Biosimilars vs originators: Are they the same?
|
Sarzi-Puttini, Piercarlo |
|
|
18 |
12 |
p. |
artikel |
3 |
Cannabinoids in the treatment of rheumatic diseases: Pros and cons
|
Sarzi-Puttini, Piercarlo |
|
|
18 |
12 |
p. |
artikel |
4 |
Can we use NOACS in APS?
|
Peleg, Hagit |
|
|
18 |
12 |
p. |
artikel |
5 |
Can we wean patients with inflammatory arthritis from biological therapies?
|
Edwards, Christopher J. |
|
|
18 |
12 |
p. |
artikel |
6 |
Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?
|
Atzeni, Fabiola |
|
|
18 |
12 |
p. |
artikel |
7 |
Does seronegative obstetric APS exist? “pro” and “cons”
|
Conti, Fabrizio |
|
|
18 |
12 |
p. |
artikel |
8 |
Editorial Board
|
|
|
|
18 |
12 |
p. |
artikel |
9 |
Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents
|
Rubbert-Roth, Andrea |
|
|
18 |
12 |
p. |
artikel |
10 |
Is there today a place for corticosteroids in the treatment of scleroderma?
|
Blagojevic, Jelena |
|
|
18 |
12 |
p. |
artikel |
11 |
Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis
|
Blockmans, Daniel |
|
|
18 |
12 |
p. |
artikel |
12 |
Should we combine biologics with methotrexate in axial spondyloarthritis?
|
Poddubnyy, Denis |
|
|
18 |
12 |
p. |
artikel |
13 |
Treatment for refractory lupus nephritis: Rituximab vs triple target therapy
|
Cervera, Ricard |
|
|
18 |
12 |
p. |
artikel |